Hood, Sean D.

A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers

Lopresti, A. L., Maker, G. L., Hood, S. D., & Drummond, P. D. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Tryptophan and brain disordersTreatment of Major Depression

Cited by 371

Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study

Lopresti, A. L., Maes, M., Maker, G. L., Hood, S. D., & Drummond, P. D. (2014) · Journal of Affective Disorders

Curcumin's Biomedical ApplicationsTreatment of Major Depression

Cited by 216

Benzodiazepine dependence and its treatment with low dose flumazenil

Hood, S. D., Norman, A., Hince, D. A., Melichar, J. K., & Hulse, G. K. (2014) · British Journal of Clinical Pharmacology

Substance Abuse Treatment and OutcomesPharmaceutical Practices and Patient Outcomes

Cited by 165

Acute Tryptophan Depletion. Part I: Rationale and Methodology

Hood, S. D., Bell, C. J., & Nutt, D. J. (2005) · Australian & New Zealand Journal of Psychiatry

Tryptophan and brain disordersNeurotransmitter Receptor Influence on Behavior

Cited by 135

The definition of treatment resistance in anxiety disorders: a Delphi method‐based consensus guideline

Domschke, K., Seuling, P. D., Schiele, M. A., Bandelow, B., Batelaan, N. M., Bokma, W. A., Branchi, I., Broich, K., Burkauskas, J., Davies, S. J. C., et al. (2024) · World Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

Cited by 46

Withdrawal and psychological sequelae, and patient satisfaction associated with subcutaneous flumazenil infusion for the management of benzodiazepine withdrawal: A case series

Hulse, G., O’Neil, G., Morris, N., Bennett, K., Norman, A., & Hood, S. (2013) · Journal of Psychopharmacology

Substance Abuse Treatment and OutcomesPoisoning and overdose treatments

Cited by 27